On Tuesday, March 7, 2019, the third annual symposium was held. The symposium featured distinguished scientists including a Nobel Prize Laureate and profiled remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors. The following list highlights featured talks:
- “Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Insights, and Prospects for Cures”
James P. Allison, PhD
Professor and Chair, Department of Immunology
University of Texas, MD Anderson Cancer Center
Nobel Prize in Physiology or Medicine 2018 - “ILC Recognition of Tumor Cells”
Marco Colonna, MD
Robert Rock Belliveau MD Professor, Pathology & Immunology - “Human Tuberculosis: A moving target”
Shabaana Khader, PhD
Professor and Interim Chair, Molecular Microbiology - “Genetic Variants in Complement Regulators Causing Human Disease”
John P. Atkinson, MD
Samuel B. Grant Professor, Medicine, Division of Rheumatology
Professor, Molecular Microbiology
